Silmäasema - Proposal by the Shareholders' Nomination Board to the Annual General Meeting 2019
Silmäasema Oyj
Stock Exchange Release
31 January 2019 at 8:30 EET
The Shareholders' Nomination Board proposes to the Annual General Meeting of Silmäasema, which is planned to be held on April 10, 2019, that the Board of Directors will have six (6) members for the term expiring at the close of the Annual General Meeting 2020.
Members of the Board
The Nomination Board proposes that from the current members of the company's Board of Directors Tuomas Lang, Maisa Romanainen, Jukka Hienonen, Torsti Sihvola and Kaisa Vikkula would be re-elected and Martti Kiuru would be elected as a new member. In addition, the Nomination Board proposes that Jukka Hienonen would be elected as the Chairman of the Board of Directors and Kaisa Vikkula would be elected as the Vice Chairman. Juha Saarinen has advised the Nomination Board, that he is not available as candidate to continue in Silmäasema's Board of Directors.
All the nominees have given their consent to the position.
Essential personal data of Mr. Martti Kiuru
Born: 1970
Education: M.D., Ph.D. and M.Sc.Tech.
Essential working experience:
- SYNLAB Suomi, CEO 2017-2019
- Cityterveys Oy, Founder and CEO 2014-2017
- Terveystalo Group, CEO and various key positions 2005-2011
- HUS-Röntgen, Head of Department 2004-2005
- Various physician and researcher positions -2004
Key positions of trust:
- CAP Group Oy, Member of the Board of Directors 2017-
- Debora Group Oy, Member of the Board of Directors 2017-
- Reseptori Oy, Founder and Member of the Board of Directors 2017-
- Emkine Oy, Founder and Member of the Board of Directors 2014-
- Staffpoint Group, Chairman of the Board of Directors 2012-2015, Member of the Board of Directors -2017
- Animagi Group, Chairman of the Board of Directors 2012-2014
Remuneration paid to the members of the Board of Directors
The Nomination Board proposes that the annual remuneration of the Board of Directors remains unchanged and is the following:
- Chairman of the Board of Directors: EUR 40,000
- Vice Chairman of the Board of Directors: EUR 22,000
- Member of the Board of Directors: EUR 22,000
In addition, the Nomination Board proposes that in accordance with previously adopted practice the members of the Board will be paid a fee for attending the meetings of the Audit Committee of 400 euros per meeting.
The Nomination Board proposes that the fees to the Board members are paid in cash.
Composition of the Nomination Board
The Nomination Board has consisted of the following representatives:
- Juhana Kallio (Chairman), Intera Partners
- Patrick Lapveteläinen, Mandatum Life Insurance Company Limited
- Timo Sallinen, Varma Mutual Pension Insurance Company
- Jukka Hienonen, Chairman of the Board of Directors of Silmäasema Oyj
Additional information
Chairman of the Nomination Board Juhana Kallio, tel. +358 40 526 6629
Chairman of the Board of Directors of Silmäasema Jukka Hienonen, tel. +358 50 388 9670
SILMÄASEMA OYJ
Jussi Salminen
CEO
Mikko Merisaari
Interim Head of Communications and Investor Relations
Silmäasema is a Finnish company, which offers all products and services for optical retail and eye healthcare nationwide. Silmäasema is the largest private eye clinic provider offering eye surgeries and the second largest optical retail chain in Finland. The Silmäasema chain has over 150 stores and 14 eye clinics in Finland as well as ten stores in Estonia. The Silmäasema chain employs close to 1,000 eye healthcare professionals. Silmäasema's Group net sales were EUR 118.3 million in 2017 and adjusted EBITDA was EUR 11.8 million.
